| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.GDE.2006.12.003 |
| P698 | PubMed publication ID | 17208429 |
| P2093 | author name string | Guillermina Lozano | |
| P2860 | cites work | Transactivation of the EGR1 gene contributes to mutant p53 gain of function | Q38334166 |
| P433 | issue | 1 | |
| P304 | page(s) | 66-70 | |
| P577 | publication date | 2007-01-08 | |
| P1433 | published in | Current Opinion in Genetics & Development | Q13505684 |
| P1476 | title | The oncogenic roles of p53 mutants in mouse models | |
| P478 | volume | 17 |
| Q84583331 | 20 years studying p53 functions in genetically engineered mice |
| Q33561621 | A planarian p53 homolog regulates proliferation and self-renewal in adult stem cell lineages |
| Q55031745 | A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53. |
| Q40209862 | Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells. |
| Q83729340 | Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms |
| Q37164157 | Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature |
| Q60950807 | Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations |
| Q37254784 | Correlation of transcription of MALAT-1, a novel noncoding RNA, with deregulated expression of tumor suppressor p53 in small DNA tumor virus models |
| Q35569705 | Cross-talk between T-Ag presence and pRb family and p53/p73 signaling in mouse and human medulloblastoma |
| Q35999401 | EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours |
| Q48579047 | Enhanced antigen detection in immunohistochemical staining using a 'digitized' chimeric antibody. |
| Q39122658 | Functions of TAp63 and p53 in restraining the development of metastatic cancer. |
| Q37075885 | Gender, mutant p53 and PML: a growing "affaire" in tumor suppression and oncogenesis. |
| Q82852435 | Genotoxic exposure: novel cause of selection for a functional ΔN-p53 isoform |
| Q36943260 | Identification and functional characterization of the human glutathione S-transferase P1 gene as a novel transcriptional target of the p53 tumor suppressor gene |
| Q24627168 | Inhibition of p53 transcriptional activity: a potential target for future development of therapeutic strategies for primary demyelination |
| Q48690318 | Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53. |
| Q51238702 | Modulation of cell death in human colorectal and breast cancer cells through a manganese chelate by involving GSH with intracellular p53 status. |
| Q38069375 | Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy |
| Q30542607 | More targets, more pathways and more clues for mutant p53. |
| Q33818479 | Mutant TP53 posttranslational modifications: challenges and opportunities. |
| Q33687048 | Mutant p53 gain-of-function in cancer |
| Q36170279 | Perturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancer |
| Q34002555 | Pla2g16 phospholipase mediates gain-of-function activities of mutant p53. |
| Q34627083 | Restoring expression of wild-type p53 suppresses tumor growth but does not cause tumor regression in mice with a p53 missense mutation |
| Q91660555 | Targeting mutant p53 in cancer: the latest insights |
| Q38184520 | The Mdm network and its regulation of p53 activities: a rheostat of cancer risk |
| Q36414431 | The downregulation of ΔNp63 in p53-deficient mouse epidermal tumors favors metastatic behavior |
| Q37602507 | The expanding universe of p53 targets |
| Q36649149 | The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss |
| Q38331206 | The role of DNA damage responses in p53 biology |
| Q37257745 | The role of p53 in pigmentation, tanning and melanoma |
| Q59053988 | Three birds with one stone |
| Q33493417 | Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression |
| Q36750166 | Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer. |
| Q89475549 | WDR74 modulates melanoma tumorigenesis and metastasis through the RPL5-MDM2-p53 pathway |
| Q37156031 | Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia |
| Q36885363 | p53 and its isoforms in cancer |
| Q39488131 | p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb |
| Q39850223 | p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug |
| Q38069463 | p53 mutations in cancer |
| Q42362115 | p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance |
| Q35004843 | p53--a Jack of all trades but master of none |
Search more.